These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 34480745)

  • 1. Effect of Amlodipine in Stroke and Myocardial infarction: A Systematic Review and Meta-analysis.
    Iyengar SS; Mohan JC; Ray S; Rao MS; Khan MY; Patted URH; Gaurav K
    Cardiol Ther; 2021 Dec; 10(2):429-444. PubMed ID: 34480745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication.
    Jeffers BW; Robbins J; Bhambri R; Wajsbrot D
    Am J Ther; 2015; 22(5):322-41. PubMed ID: 25738570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Jeffers BW; Robbins J; Bhambri R
    Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
    Wright JT; Dunn JK; Cutler JA; Davis BR; Cushman WC; Ford CE; Haywood LJ; Leenen FH; Margolis KL; Papademetriou V; Probstfield JL; Whelton PK; Habib GB;
    JAMA; 2005 Apr; 293(13):1595-608. PubMed ID: 15811979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers versus other classes of drugs for hypertension.
    Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers versus other classes of drugs for hypertension.
    Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials.
    Chen GJ; Yang MS
    PLoS One; 2013; 8(3):e57854. PubMed ID: 23483932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
    Zhang L; Yang J; Li L; Liu D; Xie X; Dong P; Lin Y
    J Comp Eff Res; 2018 Jul; 7(7):651-660. PubMed ID: 29888950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy.
    Opie LH; Schall R
    J Am Coll Cardiol; 2002 Jan; 39(2):315-22. PubMed ID: 11788225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of L/N-type and L-type calcium channel blockers on post-infarct cardiac remodelling in spontaneously hypertensive rats.
    Naseratun N; Kobara M; Watanabe Y; Toba H; Nakata T
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1545-1553. PubMed ID: 32323339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amlodipine and cardiovascular outcomes in hypertensive patients: meta-analysis comparing amlodipine-based versus other antihypertensive therapy.
    Lee SA; Choi HM; Park HJ; Ko SK; Lee HY
    Korean J Intern Med; 2014 May; 29(3):315-24. PubMed ID: 24851066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.
    Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
    Pharmacogenet Genomics; 2009 Jun; 19(6):415-21. PubMed ID: 19352213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in hypertensive patients with myocardial infarction or heart failure: a systematic review and meta-analysis.
    Ohtsubo T; Shibata R; Kai H; Okamoto R; Kumagai E; Kawano H; Fujiwara A; Kitazono T; Murohara T; Arima H
    Hypertens Res; 2019 May; 42(5):641-649. PubMed ID: 30948834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.